SIMANTOV RONIT (CMO & Chief Scientific Officer) received a stock award from GAMIDA CELL LTD.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/10/2023ACC: 0001209191-23-008566
Officer· CMO & Chief Scientific Officer
Since Nov 2022
+174.44K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
174.44K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+58.10K
Price / share
—
Trade value
—
% of position
49.5%
2/8/2023
117.48K→175.58K
Total
Net shares
+58.10K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 2/8/2023 | A · Award | +58.10K | — | — | 49.5% | 117.48K | 175.58K |
| Total | +58.10K | $0.00 | ||||||
Derivative Transactions1
Employee Share Option (Right to Buy)
Direct
Converts to
Ordinary Shares
116.34K shares
Shares
+116.34K
Strike price
1.59
Held after
116.34K
Exercisable
—
2/8/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Share Option (Right to Buy) Direct | Ordinary Shares116.34K shares | 2/8/2023 | A · Award | +116.34K | 1.59 | — | 116.34K |